| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0360-3016(99)00188-1 |
| P698 | PubMed publication ID | 10487550 |
| P50 | author | Ming-Sound Tsao | Q47492209 |
| P2093 | author name string | V Sharma | |
| C S Wong | |||
| M Pintilie | |||
| B J Cummings | |||
| W B Chapman | |||
| P2860 | cites work | p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! | Q72730267 |
| Properties of HPV-positive and HPV-negative anal carcinomas | Q73027872 | ||
| Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and | Q73368699 | ||
| Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group | Q77214099 | ||
| The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 | Q24317677 | ||
| P53, cell cycle control and apoptosis: Implications for cancer | Q28611435 | ||
| p53 is required for radiation-induced apoptosis in mouse thymocytes | Q29620281 | ||
| Sexually transmitted infection as a cause of anal cancer | Q34445094 | ||
| p53 function and dysfunction | Q35721291 | ||
| An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms | Q38484544 | ||
| Immunohistochemical analysis of p53 expression in anal squamous neoplasia | Q39613923 | ||
| Anal carcinoma?a histological review | Q40495400 | ||
| Implications of the p53 tumor-suppressor gene in clinical oncology. | Q40500755 | ||
| The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy | Q41240221 | ||
| Transformation associated p53 protein is encoded by a gene on human chromosome 17. | Q41992151 | ||
| Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study | Q44040804 | ||
| Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. | Q44300727 | ||
| Anal carcinoma: a clinical approach to p53 and RB gene proteins. | Q51012783 | ||
| Thymocyte apoptosis induced by p53-dependent and independent pathways. | Q54242475 | ||
| Combined therapy for cancer of the anal canal: a preliminary report | Q69769686 | ||
| Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity | Q70138565 | ||
| Site-specific comparison of p53 immunostaining in squamous cell carcinomas | Q71693253 | ||
| Immunohistochemical detection of mutant P53 protein and human papillomavirus-related E6 protein in anal cancers | Q72562830 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 309-314 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal | |
| P478 | volume | 45 |
| Q33627858 | Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases |
| Q50354455 | HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma |
| Q34276791 | Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm? |
| Q38672075 | Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention. |
| Q34433781 | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
| Q37072485 | Prognostic factors for squamous cell cancer of the anal canal |
| Q57617855 | Proliferation parameters in epidermoid carcinomas of the anal canal |
| Q73174036 | Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy |
| Q46961997 | The bottom line: outcomes after conservation treatment in anal cancer |
| Q43631944 | The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy |
| Q79907834 | [Initial pretherapeutic assessment of anal epidermoid carcinoma] |
Search more.